![Sensors | Free Full-Text | Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies | HTML Sensors | Free Full-Text | Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies | HTML](https://www.mdpi.com/sensors/sensors-19-04257/article_deploy/html/images/sensors-19-04257-g002.png)
Sensors | Free Full-Text | Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies | HTML
![SciELO - Brasil - Serological markers and risk factors for hepatitis B and C viruses in patients infected with human immunodeficiency virus Serological markers and risk factors for hepatitis B and C SciELO - Brasil - Serological markers and risk factors for hepatitis B and C viruses in patients infected with human immunodeficiency virus Serological markers and risk factors for hepatitis B and C](https://minio.scielo.br/documentstore/1678-9946/KPZGM86xQJ8NTwNt7SKLfXq/8f59da7391ec410f057119eeaad2246aa92df913.gif)
SciELO - Brasil - Serological markers and risk factors for hepatitis B and C viruses in patients infected with human immunodeficiency virus Serological markers and risk factors for hepatitis B and C
![SciELO - Brasil - Primary screening of blood donors by nat testing for HCV-RNA: development of an "in-house" method and results Primary screening of blood donors by nat testing for HCV-RNA: development SciELO - Brasil - Primary screening of blood donors by nat testing for HCV-RNA: development of an "in-house" method and results Primary screening of blood donors by nat testing for HCV-RNA: development](https://minio.scielo.br/documentstore/1678-9946/4wJRy8HMzmLfWWHh6cKWJCm/ce95409009cbec6f6d6e56059f4e1e94d5ac4efa.gif)
SciELO - Brasil - Primary screening of blood donors by nat testing for HCV-RNA: development of an "in-house" method and results Primary screening of blood donors by nat testing for HCV-RNA: development
![Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study | BMC Infectious Diseases | Full Text Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study | BMC Infectious Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-019-3832-7/MediaObjects/12879_2019_3832_Fig1_HTML.png)
Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study | BMC Infectious Diseases | Full Text
![Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization - ScienceDirect Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1074761321005367-fx1.jpg)
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization - ScienceDirect
![Role of signal-to-cut-off ratios of anti-hepatitis C virus antibody by enzyme immunoassays along with ID-NAT for screening of whole blood donors in India Arora S, Doda V - Asian J Transfus Sci Role of signal-to-cut-off ratios of anti-hepatitis C virus antibody by enzyme immunoassays along with ID-NAT for screening of whole blood donors in India Arora S, Doda V - Asian J Transfus Sci](https://www.ajts.org/articles/2016/10/1/images/AsianJTransfusSci_2016_10_1_75_165838_f4.jpg)
Role of signal-to-cut-off ratios of anti-hepatitis C virus antibody by enzyme immunoassays along with ID-NAT for screening of whole blood donors in India Arora S, Doda V - Asian J Transfus Sci
![Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort | BMC Infectious Diseases | Full Text Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort | BMC Infectious Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3367-3/MediaObjects/12879_2018_3367_Fig1_HTML.png)
Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort | BMC Infectious Diseases | Full Text
![Systematic Reviews and Evidence Summaries - WHO Guidelines on Hepatitis B and C Testing - NCBI Bookshelf Systematic Reviews and Evidence Summaries - WHO Guidelines on Hepatitis B and C Testing - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK442287/bin/annex5f49.jpg)
Systematic Reviews and Evidence Summaries - WHO Guidelines on Hepatitis B and C Testing - NCBI Bookshelf
![Routine HIV screening among blood donors in Buenos Aires (Argentina): Results from six years' experience and report of a single window-period donation | Enfermedades Infecciosas y Microbiología Clínica Routine HIV screening among blood donors in Buenos Aires (Argentina): Results from six years' experience and report of a single window-period donation | Enfermedades Infecciosas y Microbiología Clínica](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/13098568:28v25n02-13098568tab03.gif?idApp=UINPBA00004N)
Routine HIV screening among blood donors in Buenos Aires (Argentina): Results from six years' experience and report of a single window-period donation | Enfermedades Infecciosas y Microbiología Clínica
![Systematic Reviews and Evidence Summaries - WHO Guidelines on Hepatitis B and C Testing - NCBI Bookshelf Systematic Reviews and Evidence Summaries - WHO Guidelines on Hepatitis B and C Testing - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK442287/bin/annex5f50.jpg)
Systematic Reviews and Evidence Summaries - WHO Guidelines on Hepatitis B and C Testing - NCBI Bookshelf
![Qualitative hepatitis C virus RNA assay identifies active infection with sufficient viral load for treatment among Phetchabun residents in Thailand | medRxiv Qualitative hepatitis C virus RNA assay identifies active infection with sufficient viral load for treatment among Phetchabun residents in Thailand | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2022/05/11/2022.05.09.22274856/F2.large.jpg)